Repeated administration of dapirolizumab pegol in a...

  • Main
  • 2017 / 08
  • Repeated administration of dapirolizumab pegol in a...

Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles

Chamberlain, Chris, Colman, Peter J, Ranger, Ann M, Burkly, Linda C, Johnston, Geoffrey I, Otoul, Christian, Stach, Christian, Zamacona, Miren, Dörner, Thomas, Urowitz, Murray, Hiepe, Falk
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2017-211388
Date:
August, 2017
File:
PDF, 1.91 MB
english, 2017
Conversion to is in progress
Conversion to is failed